4//SEC Filing
Murray Stephen R 4
Accession 0001209191-09-000987
CIK 0001062216other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:15 PM ET
Size
9.3 KB
Accession
0001209191-09-000987
Insider Transaction Report
Form 4
Murray Stephen R
Chief Medical Officer
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-01-05$0.06/sh−200,000$12,000→ 200,000 totalExercise: $0.55Exp: 2018-01-31→ Common Stock (200,000 underlying) - Disposition from Tender
Common Stock
2009-01-01$0.61/sh−9,940$6,063→ 0 total - Disposition to Issuer
Common Stock
2009-01-05$0.61/sh−1,947$1,188→ 0 total
Footnotes (2)
- [F1]Represents shares purchased under the Issuer's Second Amended and Restated 2004 Employee Stock Purchase Plan.
- [F2]This option, which provided for quarterly vesting over four years commencing on the grant date, was canceled in connection with the Issuer's merger with 900 North Point Acquisition Corporation on January 5, 2009. In exchange, the Reporting Person received a cash payment of $12,000, which represents the difference between the exercise price of the option and the offer price of $0.61 per share multiplied by the number of shares underlying the option.
Documents
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeother
Related Parties
1- filerCIK 0001359694
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:15 PM ET
- Size
- 9.3 KB